Alembic Pharmaceuticals Limited has informed the Exchange about General Updates - Incorporation of Subsidiary Company.
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Alembic Pharmaceuticals has incorporated a new subsidiary named Alembic Lifesciences Philippines Inc. in the Philippines. The new subsidiary has a share capital of PHP 12 million (1.2 million shares at PHP 10 each). Alembic Pharmaceuticals holds 99.99% stake in this entity. The subsidiary is yet to commence business operations and has nil turnover currently. The purpose of this incorporation is to explore new business opportunities and promote, sell and distribute pharmaceutical products of the company in the Philippines market. This represents the company's strategic expansion into the Philippines geography.
The incorporation of this subsidiary signals Alembic's intent to expand its geographic footprint in international markets. However, with the subsidiary yet to commence operations and having nil turnover, the near-term financial impact on the parent company will be minimal.